SCHEMBL19318052

SCHEMBL19318052

Brc1ncc2ccc3ccccc3c2n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
HSD17B10 Q99714 2/20 0.42
CYP2A6 P11509 2/20 0.42
TSHR P16473 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
KDM4E B2RXH2 2/20 0.41
GPR3 P46089 1/20 0.41
POLB P06746 1/20 0.39
HPRT1 P00492 1/20 0.39
CYP3A4 P08684 2/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
CYP1B1 Q16678 2/20 0.37
CYP1A1 P04798 1/20 0.37
CYP1A2 P05177 1/20 0.37
MAPT P10636 4/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 2/20 0.37
RECQL P46063 1/20 0.37
CLK1 P49759 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30783275 1.00 ALDH1A1 (0.42) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL22349597 0.76 ALDH1A1 (0.42) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL17532736 0.76 CYP2A6 (0.44) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL28416889 0.76 NPC1 (0.46) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL18017046 0.76 MAPT (0.44) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL22136018 0.76 CLK1 (0.62) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL6650723 0.76 ALDH1A1 (0.38) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL24770218 0.75 ALDH1A1 (0.35) ALDH1A1HSD17B10TDP1KDM4EGPR3
SCHEMBL24767902 0.74 LMNA (0.61) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL31006418 0.73 SMN1; SMN2 (0.64) ALDH1A1HSD17B10CYP2A6TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117534666-A Amine derivative organic compound, application thereof and perovskite solar cell 北京绿人科技有限责任公司 2024-02-09 CN disclosed
US-20170256723-A1 ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2017-09-07 US disclosed
US-20170256723-A1 ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2017-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170256723-A1 ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC OPTOELECTRONIC DEVICE OR10J3, OR51E2, RPS10 ALDH1A1 649/4885HSD17B10 1109/4885CYP2A6 2484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.